2024 Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship


Descriptions

Opportunity type:

Postdoctoral Funding

Sponsor:

Cancer Research Institute

Award amount and duration:

$228,000 over three years

Currency:

USD

Eligibility

Type:
Postdoc
  • Applicants for the CRI Irvington Postdoctoral Fellowship Program must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
  • Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
  • Applicants with 5 or more years of relevant postdoctoral experience at the time of award activation are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
  • Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.
  • The fellowship can be performed in the United States or abroad but must take place at a non-profit institution. There are no citizenship restrictions.
  • Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.
  • Resubmissions: Applicants are permitted to resubmit their fellowship application at a subsequent deadline provided that the new application is improved to reflect progress. Changes to the application should be addressed within the subsequent application.

Summary

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.

A panel of scientists drawn from our Scientific Advisory Council rigorously evaluates each candidate, the intended sponsor and training environment, and the nature and feasibility of the proposed project.

The Cancer Research Institute recognizes that getting to the next great breakthrough in cancer treatment will require continued investment in fundamental research and training. CRI, therefore, invites postdoctoral fellows working in both fundamental immunology and tumor immunology to apply for funding. 

CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor should make every effort to demonstrate the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer.

Newly awarded fellowships provide a stipend of $74,000 for the first year, $76,000 for the second year, and $78,000 for the third year. An allowance of $5,000 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, health insurance, and/or childcare. 

Overhead

Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. Payments are made monthly in U.S. currency to the host institution.


Deadlines

Application deadlines

RSO detailed review deadline

Date:
February 15, 2024 - 12:00 PM

RSO final internal review deadline

Date:
February 27, 2024 - 12:00 PM

Program application deadline

Date:
March 1, 2024 - 3:00 PM

Approvals

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

  • Principal Investigator
  • Department Head
  • Faculty ADR/Dean
  • Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.



Contact Details


Keywords

Cancer Research Institute (CRI)
Cancer
Postdoctoral
Oncology
Immunology